AI assistant
JOHNSON & JOHNSON — Director's Dealing 2025
Aug 26, 2025
29750_dirs_2025-08-25_281cd019-19d3-445e-9093-a031d8744f84.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-08-22
Reporting Person: Duato Joaquin (Director, CEO and Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-22 | Common Stock | M | 125824 | $101.87 | Acquired | 401791 | Direct |
| 2025-08-22 | Common Stock | S | 125824 | $179.2079 | Disposed | 275967 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-22 | Employee Stock Options (Right to Buy) | $101.87 | M | 125824 | Disposed | 2026-02-08 | Common Stock (125824) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 974 | Indirect |
| Common Stock | 130852 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $178.985 to $179.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).
F3: Vested and exercisable one day after the third anniversary of the date of the grant.